TIDMCOS

Collagen Solutions PLC

07 November 2018

7 November 2018

Collagen Solutions plc

("Collagen Solutions" or the "Company")

Investor presentation

Collagen Solutions Plc (AIM: COS), the developer and manufacturer of medical grade collagen-based biomaterials for use in research, diagnostics, medical devices, and regenerative medicine, announces it will hold an investor results presentation on Tuesday, 4 December 2018.

The investor event will take place at The Brand Exchange, 3 Birchin Lane, London EC3V 9BW at 4.30pm for a 4.45pm start. This will be followed by drinks and canapes, and a chance to network.

Jamal Rushdy, CEO, and Hilary Spence, CFO, will summarise the half year results and present the key financial highlights, outlook and future vision and how they plan to deliver on the Company's growth strategy.

If you would like to register to attend the investor briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com.

 
 Collagen Solutions Plc 
 Jamal Rushdy, CEO                                                  Via Walbrook 
 Hilary Spence, CFO 
 
 Cenkos Securities Plc (Nominated 
  Adviser and Broker) 
 Steve Cox (Corporate Finance)                                Tel: 0207 397 8900 
 Stephen Keys 
 
 Walbrook PR Ltd                   Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Anna Dunphy                                                  Mob: 07876 741 001 
 Helen Cresswell                                              Mob: 07841 917 679

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic(R). The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRADMMGMFVFGRZM

(END) Dow Jones Newswires

November 07, 2018 02:00 ET (07:00 GMT)

Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Healthcare Inv Charts.
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Healthcare Inv Charts.